(-0.41%) 5 460.48 points
(-0.12%) 39 119 points
(-0.71%) 17 733 points
(-0.34%) $81.46
(-3.13%) $2.60
(0.01%) $2 336.90
(0.61%) $29.44
(0.28%) $1 009.00
(-0.06%) $0.933
(0.45%) $10.68
(-0.05%) $0.791
(0.86%) $85.73
Live Chart Being Loaded With Signals
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States...
Stats | |
---|---|
Šios dienos apimtis | 1.09M |
Vidutinė apimtis | 1.27M |
Rinkos kapitalizacija | 371.20M |
EPS | $-0.0159 ( Q1 | 2024-05-09 ) |
Kita pelno data | ( $0 ) 2024-08-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
70.00 (Sector) 42.63 (Industry) 0 |
ATR14 | $0.00500 (0.18%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-19 | Cavorsi Robert | Sell | 0 | Class A Common Stock |
2024-04-19 | Cavorsi Robert | Sell | 0 | Class A Common Stock |
2024-04-19 | Cavorsi Robert | Sell | 0 | Class A Common Stock |
2024-04-19 | Cavorsi Robert | Sell | 0 | Class A Common Stock |
2024-04-19 | Cavorsi Robert | Sell | 0 | Class A Common Stock |
INSIDER POWER |
---|
71.93 |
Last 100 transactions |
Buy: 10 063 749 | Sell: 1 162 734 |
Tūris Koreliacija
Organogenesis Holdings Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
SSTI | 0.919 |
WBD | 0.915 |
RDUS | 0.913 |
RIVN | 0.913 |
FWRD | 0.91 |
AUUD | 0.908 |
QNRX | 0.907 |
RUN | 0.906 |
BNRG | 0.905 |
PACB | 0.905 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
TSCO | -0.893 |
DXJS | -0.891 |
CDRO | -0.89 |
IBKR | -0.886 |
PNTG | -0.884 |
ACGL | -0.884 |
SHLD | -0.883 |
WING | -0.883 |
GOGL | -0.882 |
ESTA | -0.882 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Organogenesis Holdings Koreliacija - Valiuta/Žaliavos
Organogenesis Holdings Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $433.14M |
Bruto pelnas: | $309.79M (71.52 %) |
EPS: | $0.0377 |
FY | 2023 |
Pajamos: | $433.14M |
Bruto pelnas: | $309.79M (71.52 %) |
EPS: | $0.0377 |
FY | 2022 |
Pajamos: | $450.89M |
Bruto pelnas: | $345.87M (76.71 %) |
EPS: | $0.120 |
FY | 2021 |
Pajamos: | $468.06M |
Bruto pelnas: | $353.86M (75.60 %) |
EPS: | $0.740 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Organogenesis Holdings
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in the native tissue are preserved; Apligraf, a bioengineered living cell therapy that produce spectrum of cytokines and growth factors; Dermagraft, a bioengineered product that produces human collagen, ECM, proteins, and cytokines; NuShield, a wound covering tissue includes both amnion and chorion membranes for spongy/intermediate layer intact; PuraPly , a antimicrobial barrier that enables conformability and fluid drainage; and Novachor, an amniotic membrane wound covering in which viable cells, growth factors/cytokines, and ECM proteins are preserved. Its surgical and sports medicine products comprise NuCel, a dehydrated placental tissue surgically applied to the target tissue to support native healing; ReNu, a cryopreserved suspension used to support healing of soft tissues; and FiberOS and OCMP used as a bone void filler primarily in orthopedic and neurosurgical applications. The company's pipeline products include PuraPly XT and PuraPly MZ to treat chronic, acute, and open wounds; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; and TransCyte, a bioengineered tissue for the treatment of partial thickness burns. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician office through direct sales force and independent agencies. The company was founded in 1985 and is headquartered in Canton, Massachusetts.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.